| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥448.1B | ¥441.8B | +1.4% |
| Operating Income | ¥30.9B | ¥32.7B | -5.5% |
| Ordinary Income | ¥30.7B | ¥33.1B | -7.2% |
| Net Income | ¥18.6B | ¥20.8B | -10.8% |
| ROE | 4.7% | 5.1% | - |
FY2026 Q3 consolidated results show revenue of 448.1B yen (YoY +1.4%), operating income of 30.9B yen (YoY -5.5%), ordinary income of 30.7B yen (YoY -7.2%), and net income attributable to owners of 18.6B yen (YoY -10.8%). The company achieved modest top-line growth but experienced margin compression at all profit levels. Gross profit margin remained solid at 56.1%, but increased selling, general and administrative expenses coupled with a high effective tax rate of 39.0% compressed net profit margin to 4.1%. Total assets decreased to 670.9B yen from 708.9B yen, while equity declined to 393.0B yen from 406.1B yen, maintaining an equity ratio of 58.6%.
Revenue increased 6.3B yen (+1.4% YoY) to 448.1B yen, driven by contributions from both reporting segments. The Medical Services segment generated external sales of 30.1B yen (up from 29.3B yen prior year), representing an increase of approximately 815M yen (+2.8%), while the Home Furnishing and Health segment recorded external sales of 14.3B yen (down slightly from 14.5B yen prior year), a decrease of approximately 159M yen (-1.1%). The modest revenue growth reflects stable demand in medical services offsetting softness in interior health products. Operating income declined 1.8B yen (-5.5% YoY) to 30.9B yen despite the revenue increase, indicating operating margin deterioration from 7.4% to 6.9%. This 0.5 percentage point margin compression stems primarily from increased SG&A expenses, which rose faster than revenue growth. Selling, general and administrative expenses increased as a percentage of sales, reflecting higher promotional costs, logistics expenses, and provisions for bonuses. Ordinary income declined 2.4B yen (-7.2% YoY) to 30.7B yen, with the gap between operating and ordinary income remaining minimal, indicating limited non-operating income volatility. Net income decreased 2.2B yen (-10.8% YoY) to 18.6B yen, with the sharper decline relative to ordinary income attributable to a high effective tax rate of 39.0% and tax burden coefficient of 0.610. The disproportionate decline in net income relative to operating income reflects elevated tax expenses rather than extraordinary items. This represents a revenue up, profit down pattern, where top-line growth was insufficient to offset operating expense inflation and tax burden increases.
The Medical Services segment is the core business, contributing 67.2% of total segment sales with 30.1B yen in external revenue. This segment recorded operating profit (segment profit) of 2.3B yen, down from 2.5B yen in the prior year, representing a decline of approximately 195M yen (-7.8%). The segment profit margin for Medical Services deteriorated to approximately 7.7% from 8.5% YoY. The Home Furnishing and Health segment generated 14.6B yen in total segment sales (including internal transfers) with operating profit of 771M yen, down from 798M yen in the prior year, a decrease of 27M yen (-3.4%). This segment's profit margin stood at approximately 5.3%, down from 5.4% YoY. Both segments experienced profit margin compression despite the Medical Services segment achieving revenue growth. The Other segment, comprising real estate leasing and other non-reportable businesses, contributed minimal sales of 409M yen with marginal profitability. Corporate adjustments showed a negative 4M yen impact in the current period versus a positive 11M yen in the prior year, primarily due to increased corporate expenses and intersegment transaction eliminations totaling 1.3B yen. The Medical Services segment's larger scale and more significant YoY profit decline indicates it is the primary driver of consolidated operating income weakness.
[Profitability] Operating margin of 6.9% represents a 0.5 percentage point decline from 7.4% YoY, while net profit margin of 4.1% decreased 0.6 percentage points from 4.7% YoY. ROE of 4.7% reflects the combination of net profit margin of 4.1%, total asset turnover of 0.668, and financial leverage of 1.71 times. ROA of 2.8% (calculated as 18.6B yen net income annualized over average assets) indicates modest asset utilization efficiency. The effective tax rate of 39.0% is elevated, with tax burden coefficient of 0.610 reducing after-tax profitability. ROIC of approximately 5% suggests returns on invested capital are modest relative to likely cost of capital. [Cash Quality] Cash and deposits of 68.7B yen cover short-term debt of 15.4B yen by 4.46 times, indicating strong immediate liquidity. However, working capital efficiency indicators show deterioration, with days sales outstanding (DSO) of 73 days, days inventory outstanding (DIO) of 117 days, and cash conversion cycle of 198 days all significantly elevated. [Investment Efficiency] Total asset turnover of 0.668 (calculated as 448.1B yen revenue / 670.9B yen total assets) is slightly above the manufacturing industry median of 0.58, indicating relatively efficient asset utilization at the aggregate level. Inventory turnover of 117 days aligns approximately with the industry median of 109 days, though absolute levels remain elevated. [Financial Health] Equity ratio of 58.6% (393.0B yen equity / 670.9B yen total assets) compares favorably to the industry median of 63.8%, indicating moderately conservative capitalization. Current ratio of 264.0% and quick ratio of 216.7% significantly exceed industry standards, demonstrating robust short-term liquidity. Interest-bearing debt totals 55.7B yen, comprising 15.4B yen in short-term borrowings and 40.3B yen in long-term debt, with debt-to-equity ratio of 0.14 and debt-to-capital ratio of 12.4%, both indicating conservative leverage. Financial leverage of 1.71 times is slightly above the industry median of 1.53, but remains within prudent ranges.
Cash and deposits decreased 19.2B yen YoY to 68.7B yen from 87.9B yen, indicating net cash outflow during the nine-month period despite positive net income generation. Total assets declined 38.0B yen to 670.9B yen from 708.9B yen, suggesting asset rationalization or valuation adjustments. Working capital dynamics reveal mixed signals, with accounts receivable (notes and trade) increasing 0.6B yen to 98.5B yen, inventory decreasing 2.9B yen to 143.6B yen, and accounts payable declining 2.0B yen to 41.1B yen. The inventory reduction contributed positively to cash generation, while accounts payable reduction represents cash outflow, reflecting payment of supplier obligations. The elevated DSO of 73 days and DIO of 117 days indicate continued working capital absorption despite period-end inventory reduction. Treasury stock increased substantially to 17.0B yen from 2.1B yen, representing 14.9B yen in share repurchases that consumed cash during the period. Goodwill decreased 1.8B yen to 2.8B yen from 4.6B yen, potentially reflecting amortization or impairment adjustments. Fixed assets remained relatively stable, with property, plant and equipment at 149.6B yen showing minimal change. The combination of declining cash, significant treasury stock purchases, reduced payables, and elevated working capital cycles suggests cash generation from operations was insufficient to fund capital allocation activities, with liquidity declining despite the company's strong current ratio. Cash coverage of short-term debt remains adequate at 4.46 times, but the trajectory of cash decline and inefficient working capital conversion warrant close monitoring for sustainability of dividend distributions and financial flexibility.
Ordinary income of 30.7B yen versus operating income of 30.9B yen indicates a non-operating net deficit of approximately 0.2B yen, suggesting minimal contribution from non-operating items with slight negative impact. The interest burden coefficient of 0.987 (EBT/EBIT) confirms that interest expenses and non-operating items had limited material effect on pre-tax earnings. Non-operating income and expenses are not itemized in the available data but the minimal gap suggests limited financial income, equity method gains, or foreign exchange impacts. Financial expenses appear modest given the low debt levels. The effective tax rate of 39.0% is elevated relative to typical Japanese corporate tax rates, suggesting limited tax benefits or presence of non-deductible expenses or regional tax variations. The tax burden coefficient of 0.610 (net income/pre-tax income) directly reduces earnings quality from a cash perspective, as high tax payments reduce distributable earnings. No material extraordinary items or non-recurring factors are explicitly disclosed in the segment notes or adjustments, indicating the profit decline is operationally driven rather than distorted by one-time events. However, the working capital inefficiency indicators, particularly the elevated cash conversion cycle of 198 days comprising 73-day DSO and 117-day DIO, raise concerns about earnings quality from a cash realization perspective. Without disclosed operating cash flow data, the conversion of reported net income into actual cash remains uncertain, but the deteriorating working capital metrics strongly suggest that reported earnings are not fully converting to cash within the period. This implies that earnings quality is impaired by accruals buildup in receivables and inventory, which may indicate revenue recognition timing issues, collection challenges, or inventory obsolescence risks. Overall, while no non-recurring distortions are evident, the combination of high tax burden and weak working capital cash conversion reduces the quality and sustainability of reported earnings.
Full-year guidance anticipates revenue of 615.0B yen, operating income of 42.0B yen, ordinary income of 42.0B yen, and net income of 26.5B yen, representing YoY changes of +1.5%, -10.5%, -10.3%, and corresponding to EPS of 79.09 yen. Through Q3 (nine months), the company has achieved 448.1B yen in revenue (72.9% of full-year target), 30.9B yen in operating income (73.5% of target), 30.7B yen in ordinary income (73.1% of target), and 18.6B yen in net income (70.2% of target). Progress rates for revenue and operating income are above the standard 75% threshold for Q3, suggesting the company is tracking slightly ahead of a linear pace. However, net income progress of 70.2% lags the expected 75% benchmark, indicating either anticipated fourth-quarter profit recovery or potential downside risk to the full-year net income target. The operating income guidance of 42.0B yen implies Q4 operating income of approximately 11.1B yen, which would represent significant sequential improvement from the Q3 nine-month run rate (average quarterly operating income of 10.3B yen). This implies a back-loaded profit profile or expectation of seasonal strength in the final quarter. Given the YoY operating profit decline guidance of -10.5%, the company is projecting continued pressure on profitability for the full year despite modest revenue growth. No guidance revision has been disclosed, suggesting management maintains confidence in achieving the targets despite Q3 progress rates showing mixed signals. Key assumptions from the forecast would typically include stable gross margins, controlled SG&A expense growth in Q4, and normalization of working capital to support cash generation, though specific assumptions are not detailed in the available disclosure. The divergence between net income progress (70.2%) and operating income progress (73.5%) suggests either higher expected tax rates or non-operating losses in Q4, introducing execution risk to the net income and EPS targets.
The company declared an interim dividend of 17.0 yen per share and forecasts a year-end dividend of 23.0 yen per share, although the full-year guidance states an annual dividend of 24.0 yen per share, creating a minor inconsistency. Using the disclosed interim dividend of 17.0 yen and assuming year-end dividend aligns with the 24.0 yen annual forecast implies approximately 7.0 yen year-end distribution. Based on the Q3 nine-month net income of 18.6B yen and total shares outstanding of 34.75 million (calculated from EPS data), the implied annualized dividend of 24.0 yen per share results in total dividend payments of approximately 834M yen, yielding a payout ratio of approximately 74.8% relative to the Q3 run-rate earnings. This elevated payout ratio indicates a shareholder-friendly policy but leaves limited earnings retention for reinvestment or buffer against profit volatility. The company also significantly increased treasury stock holdings from 2.1B yen to 17.0B yen, representing share repurchases of approximately 14.9B yen during the period. Combining the annualized dividend (834M yen estimated) with the 14.9B yen in share buybacks yields a total shareholder return of approximately 15.7B yen, which against the Q3 net income of 18.6B yen results in a total return ratio of approximately 84.6%. This indicates the company is returning the substantial majority of earnings to shareholders through both dividends and buybacks. The high total return ratio enhances near-term shareholder value but raises sustainability questions if earnings decline or working capital demands increase, as internal cash generation may become insufficient to maintain both distribution levels and operational flexibility. The company's low debt levels and strong balance sheet provide some cushion, but the trajectory of declining cash balances and high payout commitments warrant close monitoring for long-term sustainability.
Elevated working capital cycle of 198 days, driven by DSO of 73 days and DIO of 117 days, substantially exceeds efficient levels and indicates significant cash tied up in receivables and inventory. This results in delayed cash realization from sales and increases exposure to bad debt risk if customers face payment difficulties, as well as inventory obsolescence risk if products age or demand shifts. The company's industry sees median operating working capital turnover of 108 days, meaning this company's 198-day cycle represents nearly double the sector norm, creating competitive disadvantage in cash generation speed and flexibility. High effective tax rate of 39.0% persistently compresses after-tax profitability, with the tax burden coefficient of 0.610 reducing net income by approximately 39% of pre-tax earnings. This elevated tax rate may stem from limited tax loss carryforwards, unfavorable regional tax jurisdictions, or non-deductible expenses, and directly reduces EPS and ROE relative to peers with lower tax burdens, potentially limiting competitiveness for capital and investor returns. Quantitatively, each 1 percentage point reduction in the tax rate would increase net income by approximately 0.3B yen, highlighting material improvement potential. SG&A expense growth outpacing revenue growth creates operating leverage risk, as the operating margin declined from 7.4% to 6.9% despite revenue increasing 1.4%. If revenue growth stalls or reverses while fixed costs remain elevated, profitability could deteriorate further, with each 1% revenue decline potentially compressing operating income by more than 1% given negative operating leverage. The segment data shows both Medical Services and Home Furnishing margins contracted, indicating broad-based cost pressure rather than isolated issues, increasing the risk that margin recovery will require structural cost actions rather than volume leverage alone.
[Industry Position] (Reference - Proprietary Analysis) The company's profitability metrics show mixed positioning relative to the manufacturing sector. Operating margin of 6.9% falls below the industry median of 8.3% (IQR: 4.8%-12.6%), placing the company in the lower half of sector profitability and indicating room for improvement in cost efficiency or pricing power. Net profit margin of 4.1% significantly underperforms the industry median of 6.3% (IQR: 3.2%-9.0%), reflecting the company's elevated tax burden and operating expense challenges. ROE of 4.7% also trails the industry median of 5.0% (IQR: 2.9%-8.1%), though remains within the typical range, suggesting capital efficiency is consistent with sector peers despite profitability headwinds. ROA of 2.8% compares unfavorably to the industry median of 3.3% (IQR: 1.8%-5.2%), indicating below-median asset productivity. Financial health indicators demonstrate relative strength, with an equity ratio of 58.6% slightly below the industry median of 63.8% (IQR: 49.5%-74.7%), indicating comparable financial conservatism and leverage. The current ratio of 264.0% substantially exceeds the industry median of 2.84x, reflecting very strong short-term liquidity positioning well above sector norms. Asset turnover of 0.668 exceeds the industry median of 0.58 (IQR: 0.42-0.66), suggesting the company achieves superior revenue generation per unit of asset base compared to typical manufacturers. However, working capital efficiency shows significant underperformance, with receivables turnover of 73 days comparing favorably to the industry median of 83 days, but inventory turnover of 117 days aligning closely with the industry median of 109 days while remaining elevated in absolute terms. The operating working capital turnover of 198 days far exceeds the industry median of 108 days (IQR: 72-143 days), placing the company in the bottom quartile for working capital efficiency and indicating substantial cash conversion disadvantage relative to peers. Revenue growth of 1.4% YoY aligns closely with the industry median of 2.7% (IQR: -1.9%-7.9%), indicating comparable top-line momentum to the sector. The company's financial leverage of 1.71x is modestly above the industry median of 1.53x (IQR: 1.31-1.85x), reflecting slightly more aggressive capital structure usage, though still within prudent ranges. Overall, the company demonstrates superior liquidity and asset turnover relative to manufacturing sector peers but underperforms on profitability margins and working capital efficiency, with particularly acute challenges in cash conversion cycle management.
Working capital efficiency represents the most significant operational challenge and improvement opportunity, with the 198-day cash conversion cycle nearly double the industry median of 108 days. Reducing DSO and DIO toward sector norms could unlock substantial cash generation without requiring revenue growth or margin expansion, potentially improving free cash flow by multiple billions of yen annually and enhancing the sustainability of the current 75% dividend payout ratio and share repurchase activity. Prioritizing receivables collection processes and inventory optimization would directly address the largest near-term risk to financial flexibility. Profitability margin compression despite revenue growth indicates an urgent need for operating leverage improvement, as SG&A expenses are growing faster than sales. The company's operating margin of 6.9% trails the industry median of 8.3% by 1.4 percentage points, representing approximately 6.3B yen in annual operating income gap if applied to current revenue levels. Management actions to control fixed costs, improve pricing discipline, or enhance product mix could restore margins toward historical and peer levels, directly translating to improved ROE and earnings sustainability. The elevated effective tax rate of 39.0% warrants strategic focus, as reducing tax burden toward more typical levels could materially enhance net income and shareholder returns without operational changes. The combination of high dividend payout ratio (75%), significant share buybacks (14.9B yen), and declining cash balances (down 19.2B yen YoY) suggests that total shareholder returns at current levels may not be sustainable from internally generated cash alone if working capital efficiency and profitability margins do not improve. Monitoring the company's ability to stabilize cash balances while maintaining capital returns will be critical for assessing long-term shareholder value creation versus short-term distribution optimization.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.